Context

Inflammatory bowel disease (IBD) is a chronic and debilitating condition affecting millions worldwide. The two main types of IBD are Crohn's disease and ulcerative colitis, both of which involve inflammation of the digestive tract. Recent research has shown that the gut microbiome, which is the collection of microorganisms that live in our intestines, plays a significant role in the development and progression of IBD. Specific types of bacteria in the gut can either contribute to or protect against inflammation, and changes in the microbiome have been linked to the onset and exacerbation of IBD symptoms. Understanding the complex interplay between the gut microbiome and IBD is a rapidly evolving field of research, and could lead to new approaches for treating and preventing this challenging condition.

IBD is a significant health concern worldwide, with over 15 million people estimated to be living with the condition. It is a chronic disease that can have a significant impact on a person's quality of life, leading to symptoms such as abdominal pain, diarrhea, fatigue, and weight loss. In addition to the physical symptoms, IBD can also have emotional and social consequences, as it can be challenging to manage and can affect a person's ability to work, travel, and participate in social activities.

Our perception of the context

Our intestines are totally unique and so is the microbiome living inside. To understand the inflammatory processes and find solutions to stop them, we approach each individual in a totally personalized way starting with the status quo of the microbiome and understanding how historical steps and lifestyle changes brought the diseases to a certain level. Based on the precise personal understanding we provide recommendations of medications that your practitioner can implement.